Vertex Pharmaceuticals Incorporated
Utility Patent Applications
Last updated:
List of all Vertex Pharmaceuticals Incorporated patents 91 in total
| Status | Patent |
|---|---|
Application | Utility: SOLID FORMS OF 3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL)CYCLOPROPANECARBOXAMIDO)-3-- METHYLPYRIDIN-2-YL) BENZOIC ACID Filling date: 13 Sep 2025 Issue date: 3 Dec 2020 |
Application | Utility: INHIBITORS OF APOL1 AND METHODS OF USING SAME Filling date: 13 Sep 2025 Issue date: 3 Dec 2020 |
Application | Utility: PROCESSES FOR PREPARING PYRROLIDINE COMPOUNDS Filling date: 13 Sep 2025 Issue date: 26 Nov 2020 |
Application | Utility: MODULATORS OF ALPHA-1 ANTITRYPSIN Filling date: 13 Sep 2025 Issue date: 19 Nov 2020 |
Application | Utility: QUINOXALINONE COMPOUNDS, COMPOSITIONS, METHODS, AND KITS FOR INCREASING GENOME EDITING EFFICIENCY Filling date: 13 Sep 2025 Issue date: 19 Nov 2020 |
Application | Utility: SOLID FORMS OF N-[2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL]-1,4-DIHYDRO-4-OXOQUINOLINE- -3-CARBOXAMIDE Filling date: 13 Sep 2025 Issue date: 12 Nov 2020 |
Application | Utility: DNA-PK INHIBITORS Filling date: 13 Sep 2025 Issue date: 12 Nov 2020 |
Application | Utility: CRYSTALLINE FORMS OF C21H22Cl2N4O2 Filling date: 13 Sep 2025 Issue date: 29 Oct 2020 |
Application | Utility: PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CFTR MEDIATED DISEASES Filling date: 13 Sep 2025 Issue date: 29 Oct 2020 |
Application | Utility: PROCESSES FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Filling date: 13 Sep 2025 Issue date: 17 Sep 2020 |
Application | Utility: MODULATOR OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, PHARMACEUTICAL COMPOSITIONS, METHODS OF TREATMENT, AND PROCESS FOR MAKING THE MODULATOR Filling date: 13 Sep 2025 Issue date: 10 Sep 2020 |
Application | Utility: Mannose Derivatives for Treating Bacterial Infections Filling date: 13 Sep 2025 Issue date: 27 Aug 2020 |
Application | Utility: COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE AND COMBINATION THERAPIES THEREOF Filling date: 13 Sep 2025 Issue date: 16 Jul 2020 |
Application | Utility: METHODS OF PREPARING INHIBITORS OF INFLUENZA VIRUSES REPLICATION Filling date: 13 Sep 2025 Issue date: 2 Jul 2020 |
Application | Utility: PHARMACEUTICAL COMPOSITIONS OF 3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIDIN-2-YL) BENZOIC ACID AND ADMINISTRATION THEREOF Filling date: 13 Sep 2025 Issue date: 25 Jun 2020 |
Application | Utility: METHODS OF TREATMENT FOR CYSTIC FIBROSIS Filling date: 13 Sep 2025 Issue date: 4 Jun 2020 |
Application | Utility: COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE Filling date: 13 Sep 2025 Issue date: 7 May 2020 |
Application | Utility: METHODS OF TREATMENT FOR CYSTIC FIBROSIS Filling date: 13 Sep 2025 Issue date: 7 May 2020 |
Application | Utility: MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS Filling date: 13 Sep 2025 Issue date: 16 Apr 2020 |
Application | Utility: DNA-PK INHIBITORS Filling date: 13 Sep 2025 Issue date: 9 Apr 2020 |
Application | Utility: FORMULATIONS OF 3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIDIN-2-YL)BENZOIC ACID Filling date: 13 Sep 2025 Issue date: 19 Mar 2020 |
Application | Utility: DNA-PK INHIBITORS Filling date: 13 Sep 2025 Issue date: 27 Feb 2020 |
Application | Utility: COMBINATION THERAPIES FOR TREATING INFLUENZA VIRUS INFECTION Filling date: 13 Sep 2025 Issue date: 20 Feb 2020 |
Application | Utility: PRODRUG OF AN ICE INHIBITOR Filling date: 13 Sep 2025 Issue date: 13 Feb 2020 |
Application | Utility: METHOD FOR TREATING CANCER USING A COMBINATION OF DNA-DAMAGING AGENTS AND DNA-PK INHIBITORS Filling date: 13 Sep 2025 Issue date: 16 Jan 2020 |
Application | Utility: METHOD OF TREATING PAIN Filling date: 13 Sep 2025 Issue date: 14 Nov 2019 |
Application | Utility: PTERIDINONE COMPOUNDS AND USES THEREOF Filling date: 13 Sep 2025 Issue date: 24 Oct 2019 |
Application | Utility: ANTIPROLIFERATION COMPOUNDS AND USES THEREOF Filling date: 13 Sep 2025 Issue date: 24 Oct 2019 |
Application | Utility: MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS Filling date: 13 Sep 2025 Issue date: 24 Oct 2019 |
Application | Utility: DNA-PK INHIBITORS Filling date: 13 Sep 2025 Issue date: 26 Sep 2019 |
Application | Utility: PHARMACEUTICAL COMPOSITION AND ADMINISTRATIONS THEREOF Filling date: 13 Sep 2025 Issue date: 12 Sep 2019 |
Application | Utility: PRODRUGS OF PYRIDONE AMIDES USEFUL AS MODULATORS OF SODIUM CHANNELS Filling date: 13 Sep 2025 Issue date: 12 Sep 2019 |
Application | Utility: MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Filling date: 13 Sep 2025 Issue date: 5 Sep 2019 |
Application | Utility: Solid Forms of (R)-1(2,2-Difluorobenzo[D][1,3]Dioxol-5-yl)-N-(1-(2,3-Dihydroxypropyl)-6-- Fluoro-2-(1-Hydroxy-2-Methylpropan-2-yl)-1H-Indol-5-yl)Cyclopropanecarboxa- mide Filling date: 13 Sep 2025 Issue date: 5 Sep 2019 |
Application | Utility: DNA-PK INHIBITORS Filling date: 13 Sep 2025 Issue date: 22 Aug 2019 |
Application | Utility: COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE Filling date: 13 Sep 2025 Issue date: 22 Aug 2019 |
Application | Utility: Modulators of Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods of Treatment, and Process for Making the Modulators Filling date: 13 Sep 2025 Issue date: 15 Aug 2019 |
Application | Utility: PYRIDONE AMIDES AS MODULATORS OF SODIUM CHANNELS Filling date: 13 Sep 2025 Issue date: 15 Aug 2019 |
Application | Utility: PHARMACEUTICAL COMPOSITIONS FOR TREATING CYSTIC FIBROSIS Filling date: 13 Sep 2025 Issue date: 8 Aug 2019 |
Application | Utility: GCN2 INHIBITORS AND USES THEREOF Filling date: 13 Sep 2025 Issue date: 1 Aug 2019 |
Application | Utility: GCN2 INHIBITORS AND USES THEREOF Filling date: 13 Sep 2025 Issue date: 1 Aug 2019 |
Showing 50 to 91 of 91 patents.